These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4783250)

  • 41. [Treatment of renal hypertension with alpha-methylodopa (Presinol) and Cyclazenin (Leron)].
    Sarre H; Oechslen D
    Med Klin; 1967 Apr; 62(14):561-5. PubMed ID: 5592469
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effect of angiotensin I converting enzyme inhibitors on renal function indicators in hypertensive patients].
    Sedlak-Vadoc V; Ubavić M; Stosić Z; Curić S
    Med Pregl; 1993; 46(3-4):87-91. PubMed ID: 7862050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antihypertensive therapy in limited renal function].
    Lübbecke F
    Fortschr Med; 1986 Nov; 104(42):793-6. PubMed ID: 3804151
    [No Abstract]   [Full Text] [Related]  

  • 44. [The kidney in essential arterial hypertension: should microalbuminuria excretion be measured?].
    García Puig J; Mateos Antón F
    Rev Clin Esp; 1995 Jun; 195(6):425-36. PubMed ID: 7644795
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of -methyldopa on renal plasma flow in patients with renal hypertension.
    Majdrakov G; Mitrov G; Mushmov D; Salambashev L; Todorov G
    Int Urol Nephrol; 1971; 3(3):289-93. PubMed ID: 5154573
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hypotensive effect of nephrectomy in malignant renal hypertension and the function of the remaining kidney at late follow-up].
    Rustamova MT; Iunusov RA
    Ter Arkh; 1984; 56(9):37-40. PubMed ID: 6515545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension of renal origin.
    Acchiardo S
    Medicina (B Aires); 1979; 39 Suppl 1():66-70. PubMed ID: 550046
    [No Abstract]   [Full Text] [Related]  

  • 49. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons learned from recent clinical trials in hypertensive diabetics: what's good for the kidney is good for the heart and brain.
    Toto RD
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):7S-10S; quiz A2-4. PubMed ID: 15539108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Quantitative radiocardiographic studies of hemodynamics in patients with renoparenchymal hypertension].
    Stefanov S; Sheĭretova E
    Vutr Boles; 1982; 21(6):26-32. PubMed ID: 7164415
    [No Abstract]   [Full Text] [Related]  

  • 52. [Radiorenography in hypertension].
    Aurell M; Berglund G; Jonsson S
    Lakartidningen; 1972 Feb; 69(8):872-8. PubMed ID: 5015728
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved renal function in patients with primary renal disease after control of severe hypertension.
    Friedlaender MM; Rubinger D; Popovtzer MM
    Am J Nephrol; 1982; 2(1):12-4. PubMed ID: 7180900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies of renal function in the acute stage of hypertensive cerebral hemorrhage--with special reference to pre- and post-surgical hematoma].
    Kuzu Y
    Shinkei Kenkyu No Shimpo; 1971; 15(4):1003-18. PubMed ID: 5168623
    [No Abstract]   [Full Text] [Related]  

  • 55. [Functioning of the kidneys on the basis of radioisotope renography in Itsenko-Cushing disease].
    Tsfasman AZ; Tslaf ZZ
    Ter Arkh; 1969 Jan; 41(1):85-8. PubMed ID: 5374613
    [No Abstract]   [Full Text] [Related]  

  • 56. [Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases].
    Risler T; Erley CM
    Z Kardiol; 1993; 82 Suppl 4():39-44. PubMed ID: 7908476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aspects of separate renal function in unilateral hypertensive pyelonephritis].
    Quarto di Palo FM; Vegeto A; Gastaldi L; Zenoni M; Grillo C
    Minerva Med; 1968 Jun; 59(46):2647-52. PubMed ID: 5671368
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of hypotensive nifedipine therapy on renal secretory function in hypertensive patients in the course of both compensated and non-compensated chronic renal failure].
    Manitius A; Manitius J; Niemierko J; Kliz J
    Pol Tyg Lek; 1992 Dec 7-14; 47(49-50):1108-10. PubMed ID: 1305737
    [No Abstract]   [Full Text] [Related]  

  • 59. [Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
    Nestor G; Beroniade V; Tutunaru M
    Med Interna (Bucur); 1970 Jul; 22(7):863-8. PubMed ID: 5479504
    [No Abstract]   [Full Text] [Related]  

  • 60. [The radionephrogram in renovascular hypertension. Comparative evaluation of data obtained by separate renal function tests].
    Giustina G; Cantalamessa L; Quartodipalo F; Gastaldi L; Vegeto A
    Minerva Cardioangiol; 1967 Jan; 15(1):4-14. PubMed ID: 5597263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.